<J GAAP> Historical data (2015-2001)
Consolidated Statement of Cash Flows
(JPY million)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Cash flows from (used in) operating activities | |||||
Profit before tax | 197,391 | 125,399 | 199,826 | 205,992 | 241,871 |
Depreciation and amortization expenses | 113,036 | 123,277 | 134,815 | 140,419 | 147,992 |
Impairment losses | 57 | 8,819 | 13,442 | 18,490 | 2,183 |
Interest and dividend income | -3,103 | -3,536 | -2,880 | -2,656 | -7,450 |
Interest expenses | 7,390 | 11,164 | 12,700 | 12,306 | 14,269 |
Share of profit (loss) of entities accounted for using equity method | -872 | -285 | -687 | -667 | -875 |
Gain on sales of investments accounted for using equity method | - | 2,300 | - | - | - |
Gain (loss) on sales of stocks of subsidiaries and affiliates | -298 | - | - | - | - |
Loss (gain) on sales and retirement of non-current assets | 3,926 | -1,839 | -31,083 | -9,540 | 3,564 |
Increase (decrease) in trade receivables | 22,881 | 48,666 | -11,812 | -826 | -23,608 |
Increase (decrease) in inventories | -10,722 | 3,306 | -14,566 | -27,957 | -24,447 |
Increase (decrease) in trade payables | 2,955 | -3,302 | 9,598 | 25,737 | 32,898 |
Decrease (increase) in accrued alcohol tax | -9,214 | -16,609 | 9,106 | -4,062 | 2,984 |
Increase (decrease) in net defined benefit assets and liabilities | 1,338 | 1,627 | 2,084 | 1,441 | 1,073 |
Other | -14,572 | 37,994 | 75,992 | 3,369 | 36,027 |
Subtotal | 310,192 | 336,982 | 396,535 | 362,049 | 426,484 |
Interest and dividends received | 3,818 | 4,182 | 3,116 | 3,344 | 7,624 |
Inrerest paid | -6,875 | -10,049 | -11,224 | -10,839 | -12,646 |
Income taxes paid | -53,666 | -55,256 | -50,615 | -88,562 | -73,914 |
Net cash flows from (used in) operating activities | 253,469 | 275,859 | 337,812 | 265,991 | 347,547 |
Cash flows from (used in) investing activities | |||||
Purchase of property, plant and equipment | -74,312 | -80,775 | -80,803 | -83,049 | -89,580 |
Proceeds from sales of property, plant and equipment | 4,564 | 12,095 | 46,321 | 25,109 | 11,710 |
Purchase of intangible assets | -11,009 | -9,968 | -11,832 | -16,796 | -20,248 |
Proceeds from intangible assets | - | - | 18,740 | 868 | - |
Purchase of investment securities | -5,841 | -10,237 | -464 | -552 | -1,292 |
Proceeds from sales of financial assets | 8,856 | 11,869 | 30,159 | 8,483 | 3,387 |
Proceeds from sales of investment in an entity accounted for using equity method | - | 1,552 | - | 676 | - |
Purchase of shares of subsidiaries and others resulting in change in scope of consolidation | -23,942 | -1,165,974 | -14,762 | -2,661 | -3,551 |
Proceeds from sales of subsidiaries and others relating to the change of scope of consolidation | 741 | 83 | 396 | 0 | - |
Payments for contingent consideration | - | - | - | -2,357 | -18,574 |
Other | -2,721 | -2,017 | -2,103 | 1,091 | 434 |
Net cash flows from (used in) investing activities | -103,666 | -1,243,372 | -14,348 | -69,186 | -117,713 |
Cash flows from (used in) financing activities | |||||
Increase (decrease) in short-term borrowings | 38,736 | 489,155 | -440,775 | -8,527 | -200,705 |
Payments of finance lease liabilities | -22,113 | -21,238 | -25,215 | -23,307 | -24,555 |
Proceeds from long-term borrowings | 1,579 | - | 191,000 | 0 | 50,000 |
Repayments of long-term borrowings | -94,569 | -100,076 | -183,688 | -51,460 | -43,062 |
Proceeds from issuance of bonds | - | 607,600 | 282,048 | 60,000 | 150,000 |
Redemption of bonds | -35,000 | -125,000 | -88,328 | -140,000 | 100,000 |
Proceeds from issuance of new shares | - | 75,027 | - | - | - |
Purchase of treasury shares | -31 | -309 | -26 | -263 | -25 |
Proceeds from disposal of treasury shares | - | 81,307 | 135 | - | - |
Dividends paid | -48,556 | -46,265 | -54,220 | -55,738 | -57,761 |
Proceeds from share issuance to non-controlling shareholders | - | 201 | - | - | - |
Other | 1,113 | -3,642 | -1,254 | -258 | -635 |
Net cash flows from (used in) financing activities | -158,841 | 956,759 | -320,325 | -219,556 | -226,746 |
Effect of exchange rate changes on cash and cash equivalents | 209 | 10,725 | 1,144 | 7,447 | 20,004 |
Net increase (decrease) in cash and cash equivalents | -8,828 | -29 | 4,283 | -15,304 | 23,093 |
Cash and cash equivalents at beginning of period | 57,317 | 48,489 | 48,460 | 52,743 | 37,438 |
Increase (decrease) in cash and cash equivalents resulted from change in scope of consolidation | - | - | - | - | -586 |
Cash and cash equivalents at the end of period | 48,489 | 48,460 | 52,743 | 37,438 | 59,945 |
Adobe® Reader™ Download
You need Free Adobe® Reader™ software to view and print Adobe PDF files. Please download with the adobe icon.